Published in J Exp Med on December 01, 1985
Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A (1987) 2.57
Btk/Tec kinases regulate sustained increases in intracellular Ca2+ following B-cell receptor activation. EMBO J (1998) 2.36
Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34
Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J (1998) 2.29
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med (1994) 2.23
B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events. J Clin Invest (1996) 1.56
Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization. J Cell Biol (1992) 1.47
Crosslinkage of B lymphocyte surface immunoglobulin by anti-Ig or antigen induces prolonged oscillation of intracellular ionized calcium. J Exp Med (1987) 1.43
Rous-Whipple Award lecture. The biology and pathology of lymphocyte Fc receptors. Am J Pathol (1998) 1.38
Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for PI3-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization. J Exp Med (1997) 1.25
Soluble antigen abrogates the appearance of anti-protein IgG1-forming cell precursors during primary immunization. Proc Natl Acad Sci U S A (1990) 1.20
Antigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19. Proc Natl Acad Sci U S A (1988) 1.18
Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation when coligated with the high-affinity Fc receptor for IgE. Proc Natl Acad Sci U S A (1996) 1.18
Efficient IgG-mediated suppression of primary antibody responses in Fcgamma receptor-deficient mice. Proc Natl Acad Sci U S A (1999) 1.08
G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. J Biol Chem (2008) 1.06
Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell Fc gamma immunoreceptor tyrosine-based inhibition motif peptide motif. Mol Cell Biol (1997) 1.06
The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody. Proc Natl Acad Sci U S A (1997) 1.04
Surface immunoglobulin-mediated B-cell activation in the absence of detectable elevations in intracellular ionized calcium: a model for T-cell-independent B-cell activation. Proc Natl Acad Sci U S A (1989) 1.02
Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol (1993) 0.98
Differential effects of B cell receptor and B cell receptor-FcgammaRIIB1 engagement on docking of Csk to GTPase-activating protein (GAP)-associated p62. J Exp Med (1997) 0.95
Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice. J Exp Med (1995) 0.85
Cellular signalling mechanisms in B lymphocytes. Biochem J (1993) 0.84
B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation. Proc Natl Acad Sci U S A (1987) 0.83
An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes. Immunology (1988) 0.82
Feedback regulation of antibody production: a role in rheumatoid arthritis? Ann Rheum Dis (1991) 0.75
Activation and proliferation signals in mouse B cells. IX. Protein kinase C activators synergize with non-mitogenic anti-immunoglobulin antibodies to drive B cells into G1. Immunology (1988) 0.75
FcγRIIb expression in early stage chronic lymphocytic leukemia. Leuk Lymphoma (2017) 0.75
A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem (1985) 90.20
The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (1984) 28.58
Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature (1984) 25.71
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J Biol Chem (1982) 16.71
Inositol trisphosphate and diacylglycerol as second messengers. Biochem J (1984) 14.37
Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med (1979) 12.22
The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem (1980) 6.02
Induction and suppression of polyclonal antibody responses by anti-Ig reagents and antigen-nonspecific helper factors: a comparison of the effects of anti-Fab, anti-IgM, and anti IgD on murine B cells. Immunol Rev (1980) 2.96
Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes. J Cell Biol (1982) 2.67
B lymphocyte receptors and polyphosphoinositide degradation. Cell (1985) 2.66
Cross-linking of B lymphocyte Fc gamma receptors and membrane immunoglobulin inhibits anti-immunoglobulin-induced blastogenesis. J Immunol (1984) 2.15
The increase in intracellular free calcium associated with IgG gamma 2b/gamma 1 Fc receptor-ligand interactions: role in phagocytosis. Proc Natl Acad Sci U S A (1984) 1.83
Control of B-lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fc-receptor molecules. J Exp Med (1976) 1.59
Regulation of growth and proliferation in B cell subpopulations. Immunol Rev (1982) 1.59
Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies. J Immunol (1983) 1.50
The Fc-receptor: its role in the transmission of differentiation signals. Immunol Rev (1980) 1.41
Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol (1976) 1.39
Activation and proliferation signals in mouse B cells. III. Intact (IGG) anti-immunoglobulin antibodies activate B cells but inhibit induction of DNA synthesis. Immunology (1984) 1.27
B cell activation. IV. Induction of cell membrane depolarization and hyper-I-A expression by phorbol diesters suggests a role for protein kinase C in murine B lymphocyte activation. J Immunol (1984) 1.21
Characterization of the soluble complex formed by reacting rabbit IgG with protein A of S. aureus. Immunochemistry (1978) 1.19
Studies of Fc gamma receptors of human B lymphocytes: phospholipase A2 activity of Fc gamma receptors. Biochemistry (1980) 1.10
Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine. Eur J Immunol (1984) 1.09
Activation and proliferation signals in mouse B cells. IV. Concanavalin A stimulates B cells to leave G0, but not to proliferate. Immunology (1984) 1.03
Stimulation of murine B cells with anti-Ig antibodies: dominance of a negative signal mediated by the Fc receptor. Eur J Immunol (1980) 1.00
Effects of tumour promoter phorbol myristate acetate on mouse lymphocytes: selective inhibition of B cell activation by mitogens and antigens. Immunology (1984) 0.96
Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cells. Immunology (1985) 0.93
Hybridoma 2.4G2: dissociation of the B-lymphocyte-triggering activity from the monoclonal anti-Fc IgG receptor antibody. Mol Immunol (1984) 0.83
Antigen-receptor interactions in the induction of B-lymphocyte unresponsiveness. Curr Top Microbiol Immunol (1977) 0.80
The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol Rev (1980) 3.53
Activation of mouse complement by different classes of mouse antibody. Immunology (1979) 2.68
B lymphocyte receptors and polyphosphoinositide degradation. Cell (1985) 2.66
Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc Natl Acad Sci U S A (1986) 2.47
Germinal centers without T cells. J Exp Med (2000) 2.25
Hepatitis-associated Australia antigen. Protein, peptides and amine acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol (1972) 1.83
Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur J Immunol (1990) 1.81
Selective effects of cyclosporin A on functional B cell subsets in the mouse. J Immunol (1980) 1.79
Selective liver targeting of antivirals by recombinant chylomicrons--a new therapeutic approach to hepatitis B. Nat Med (1995) 1.77
The generation of memory cells. II. Generation of B memory cells with preformed antigen-antibody complexes. Immunology (1978) 1.60
The generation of memory cells. I. The role of C3 in the generation of B memory cells. Immunology (1977) 1.59
Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes. Proc Natl Acad Sci U S A (1986) 1.53
G protein coupling of antigen receptor-stimulated polyphosphoinositide hydrolysis in B cells. J Immunol (1988) 1.45
Dendritic cells associated with plasmablast survival. Eur J Immunol (1999) 1.44
Cross-linking of surface immunoglobulin on B lymphocytes induces both intracellular Ca2+ release and Ca2+ influx: analysis with indo-1. Biochem Biophys Res Commun (1986) 1.44
Generation of memory cells. III. Antibody class requirements for the generation of B-memory cells by antigen--antibody complexes. Immunology (1979) 1.43
Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. J Biol Chem (2000) 1.39
Effects of cyclosporin A on the immune system of the mouse. I. Evidence for a direct selective effect of cyclosporin A on B cells responding to anti-immunoglobulin antibodies. Eur J Immunol (1982) 1.38
The influence of epitope density on the immunological properties of hapten-protein conjugates. I. Characteristics of the immune response to hapten-coupled albumen with varying epitope density. Cell Immunol (1974) 1.37
A quantitative study of the transfer of colostral immunoglobulins to the newborn calf. Immunology (1969) 1.37
Antigen-antibody complexes elicit anti-idiotypic antibodies to self-idiotopes. Nature (1978) 1.36
The immunological properties of haptens coupled to thymus-independent carrier molecules. I. The characteristics of the immune response to dinitrophenyl-lysine-substituted pneumococcal polysaccharide (SIII) and levan. Eur J Immunol (1974) 1.35
Receptor signalling and crosstalk in B lymphocytes. Immunol Rev (1987) 1.33
Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int Immunol (2000) 1.33
Hypercross-linking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40. J Immunol (1994) 1.30
Cytochalasin B. Dissociation of pinocytosis and phagocytosis by peritoneal macrophages. Exp Cell Res (1973) 1.28
Activation and proliferation signals in mouse B cells. III. Intact (IGG) anti-immunoglobulin antibodies activate B cells but inhibit induction of DNA synthesis. Immunology (1984) 1.27
Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity (1994) 1.26
Activation and proliferation signals in mouse B cells. I. A comparison of the capacity of anti-Ig antibodies or phorbol myristic acetate to activate B cells from CBA/N or normal mice into G1. Eur J Immunol (1984) 1.24
Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains. Clin Exp Immunol (1980) 1.23
Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol (1998) 1.22
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv Drug Deliv Rev (2001) 1.17
Inhibition of antibody production in plasmacytoma cells by antigen. Eur J Immunol (1977) 1.17
B cell tolerance induced by polymeric antigens. I. Comparison of the dose and epitope density requirements for inactivation of primed and unprimed B cells in vivo. Eur J Immunol (1976) 1.17
Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies. Eur J Immunol (1994) 1.14
C3 activation and T-independent B cell stimulation. Nature (1974) 1.11
The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol (1995) 1.09
Activation and proliferation signals in mouse B cells. II. Evidence for activation (G0 to G1) signals differing in sensitivity to cyclosporine. Eur J Immunol (1984) 1.09
Activation and proliferation signals in mouse B cells. VIII. Induction of DNA synthesis in B cells by a combination of calcium ionophores and phorbol myristate acetate. Eur J Immunol (1986) 1.09
Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell help. Eur J Immunol (1999) 1.07
Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice. Eur J Immunol (1989) 1.07
Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells. J Immunol (1998) 1.07
The role of germinal centres in the generation of immunological memory. Ciba Found Symp (1981) 1.06
The immunoglobulin response in intact and splenectomized calves infected with Anaplasma marginale. J Immunol (1968) 1.06
G protein regulation of receptor signalling. Immunol Today (1988) 1.05
The immunological properties of haptens coupled to thymus-independent carrier molecules. III. The role of the immunogenicity and mitogenicity of the carrier in the induction of primary IgM anti-hapten responses. Eur J Immunol (1975) 1.05
B cells from CBA/N mice do not proliferate following ligation of CD40. Eur J Immunol (1994) 1.03
Activation and proliferation signals in mouse B cells. IV. Concanavalin A stimulates B cells to leave G0, but not to proliferate. Immunology (1984) 1.03
BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Oncogene (2001) 1.03
CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells. Int Immunol (1998) 1.02
The immunological properties of haptens coupled to thymus-independent carrier molecules. IV. The IgG response to dinitrophenylated Ficoll. Eur J Immunol (1976) 1.01
Immune complexes and the problem of immunological memory. Ann Immunol (Paris) (1982) 1.00
Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors. J Immunol (1998) 0.99
Lactoferrin uptake by the rat liver. Characterization of the recognition site and effect of selective modification of arginine residues. J Biol Chem (1992) 0.99
Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens. Immunology (1984) 0.98
Antigen-antibody complexes suppress antibody production by mouse plasmacytoma cells in vitro. Eur J Immunol (1978) 0.96
Effects of tumour promoter phorbol myristate acetate on mouse lymphocytes: selective inhibition of B cell activation by mitogens and antigens. Immunology (1984) 0.96
Removal of 14 N-terminal amino acids of lactoferrin enhances its affinity for parenchymal liver cells and potentiates the inhibition of beta- very low density lipoprotein binding. J Biol Chem (1993) 0.95
B cell tolerance induced by polymeric antigens. IV. Antigen-mediated inhibition of antibody-forming cells. Eur J Immunol (1976) 0.95
Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes. Eur J Immunol (1994) 0.94
Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cells. Immunology (1985) 0.93
Endocytosis and breakdown of ribonuclease oligomers by sinusoidal rat liver cells in vivo. II. Effect of charge. Biochim Biophys Acta (1979) 0.93
Cytochalasin B. Dissociation of pinocytosis and phagocytosis by peritoneal macrophages. Exp Eye Res (1973) 0.92
The plasma volume of the Wistar rat in relation to the body weight. Experientia (1981) 0.92
Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor. J Med Chem (1999) 0.92
B cell tolerance induced by polymeric antigens. II. Effects of tolerance on hapten-binding lymphocyte levels in primary and secondary antibody responses. Eur J Immunol (1976) 0.91
Follicular trapping of hapten-erythrocyte-antibody complexes in mouse spleen. Immunology (1984) 0.91
Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli. Eur J Immunol (1996) 0.91
Mechanisms of b cell triggering: studies with t cell-independent antigens. Transplant Rev (1975) 0.91
Cooperation between antigen-reactive T cells and anti-idiotypic B cells in the anti-idiotypic response to antigen-antibody complexes. Nature (1979) 0.91
Activation and proliferation signals in mouse B cells. VII. Calcium ionophores are non-mitogenic polyclonal B-cell activators. Immunology (1985) 0.89
Regulation of surface IgM- and IgD-mediated inositol phosphate formation and Ca2+ mobilization in murine B lymphocytes. Eur J Immunol (1989) 0.89
Receptor-mediated uptake of low-density lipoprotein by B16 melanoma cells in vitro and in vivo in mice. Br J Cancer (1996) 0.89
Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes. Immunology (1985) 0.89
Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors. Mol Pharmacol (1998) 0.88
Lysine-based cluster mannosides that inhibit ligand binding to the human mannose receptor at nanomolar concentration. J Biol Chem (1996) 0.88
Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. Mol Pharmacol (1997) 0.87
Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo. Biochem J (1999) 0.86
Mechanisms of B-cell tolerance. Br Med Bull (1976) 0.86
Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand. Int Immunol (1993) 0.85
Pyrrolidonecarboxylic acid at the N-terminal positions of polypeptide chains from leopard shark immunoglobulins. J Immunol (1970) 0.84
Concanavalin A induces Ca2+ mobilization, but only minimal inositol phospholipid breakdown in mouse B cells. J Immunol (1986) 0.84
B cell tolerance induced by polymeric antigens. VI. Kinetics and reversibility of the inhibition of antibody-forming cells by antigen. Eur J Immunol (1976) 0.84
Antagonists of the mannose receptor and the LDL receptor-related protein dramatically delay the clearance of tissue plasminogen activator. Circulation (1997) 0.84
Plasma clearance and endocytosis of mitochondrial malate dehydrogenase in the rat. Biochem J (1981) 0.83
Selective induction of cytochrome P450 3A1 by dexamethasone in cultured rat hepatocytes: analysis with a novel reverse transcriptase-polymerase chain reaction assay section sign. Biochem Pharmacol (2000) 0.83
Several dehydrogenases and kinases compete for endocytosis from plasma by rat tissues. Biochem J (1985) 0.83
Inhibition of lipopolysaccharide-induced activation of immature B cells by anti-mu and anti-delta antibodies and its modulation by interleukin-4. Int Immunol (1992) 0.83
Endocytosis and breakdown of mitochondrial malate dehydrogenase in the rat in vivo. Effects of suramin and leupeptin. Biochem J (1982) 0.83
B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation. Proc Natl Acad Sci U S A (1987) 0.83
Co-cross-linking of surface immunoglobulin Fc gamma receptors on B lymphocytes uncouples the antigen receptors from their associated G protein. Eur J Immunol (1989) 0.82
Lipoprotein receptors and atherogenic receptor-mediated mechanisms. Curr Opin Lipidol (1994) 0.82